System Transmission

Top Signal

100#1 JOB

Activity

2179Ripe

+938 today

System

Livenow

Terminal Asset View

stockNASDAQ

CABA

$3.06-4.08%

Cabaletta Bio Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

30Overripe

Live Analysis Active

Company Mission

Cabaletta Bio develops cell therapies that help the immune system fight autoimmune diseases like lupus and rheumatoid arthritis. Doctors and hospitals would use these treatments for patients whose immune systems attack their own bodies. The company makes money through research partnerships and hopes to earn revenue from selling approved treatments in the future.

CAB

Industry Context

Cabaletta operates in the biotechnology industry, which focuses on developing medical treatments using biological systems. This sector experiences significant price movements around clinical trial results and regulatory decisions, as these events determine whether experimental treatments become approved drugs.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

82Matrix

Market Momentum

49.9— Holding Steady

Trend Strength

50— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.5x— Normal Volume

Today's Change

-4.08%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing CABA across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 12:54 PM UTC

As-of 03-15-2026 12:39 UTC

Develops cell therapies that treat autoimmune diseases and makes money by selling these treatments to hospitals and clinics.

Weekly price range has been narrowing for several weeks, suggesting the stock is coiling tighter before a potential significant move.

Biotech sector volatility often increases during clinical trial announcements, making this coiling pattern worth watching for news catalysts.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...